NemoClaw - Page 4
Stories from NemoClaw come first, newest first, then stories from connected topics (OpenClaw, Open Source, Nvidia, AI Agents, AI Agents, AI), each labelled with where it comes from. This view is not indexed by search engines.
Explore related topics in the Atlas →
Latest
Google Moves Agent Substrate, gVisor and OpenRL to CNCF
Agent Substrate: Google donates Agent Substrate, gVisor and OpenRL to CNCF Sandbox; Substrate 1.0 GA on GKE. Performance figures are Google’s claims.
Google Smartwatch AI Flags Hypertension in Nature Study
Hypertension detection: Google Research Nature study; 65.8% sensitivity, 90% specificity vs 24-hour ABPM; research only, not a diagnosis product.
Factory Acquires HumanLayer and Will Open-Source Platform
Factory HumanLayer: Factory acquires HumanLayer; platform up ≥30 days then open-sourced; founders join; multiplayer coming to Factory. Price undisclosed.
Dialpad and Ada Combining Ahead of Mid-November Close
Dialpad Ada: combining for an agentic OS for customer work; close on or about 12 Nov 2026. Terms undisclosed; Walker CEO, Murchison chief AI officer.
Saildrone and Umoe Sign Surveyor V3 Production Deal
Saildrone Surveyor: Saildrone and Umoe Mandal sign a Euronaval production deal for next-gen Surveyor USVs built in Norway for Northern European navies.
OpenAI Launches GPT-6 Cyber for Defensive Research
GPT-6 Cyber: OpenAI says its cyber model scores 48.5% on ExploitGym and helped produce 948 Linux LPE exploits in a controlled research pipeline.
NYU Links ESCO2 Loss to PARP Inhibitor Sensitivity
PARP inhibitors: NYU maps ESCO2 loss as a sensitivity marker in cancer cell models via G4 stress — biomarkers, not a new therapy; more research needed.
Dropbox Plans to Acquire Tigris for Agent Cloud Storage
Dropbox Tigris: planned acquisition plus DBX Agent Cloud with standalone S3-compatible object storage first. Not closed; no official price.
Google Makes Gemini Omni 1.2 Flash Generally Available
Gemini Omni 1.2 Flash is generally available: native 15s video, $0.07/s at 720p (30% less than 1.1), multi-turn editing, SynthID.
Shield to Buy Echodyne for $5.3bn and Raise $2.5bn
Shield Echodyne deal: $5.3bn acquisition ($4.8bn at close + up to $500m contingent) and $2.5bn raise at $28.8bn post-money; close expected early 2027.
Latest on TSN
Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.